Exchange: NASDAQ
Industry: Drug Manufacturers/Other
Last Trade: 1:10 PM ET 2/10/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.29 | 1.16 | 11.21 |
| EPS, GAAP | 1.02 | 0.52 | 96.15 |
| Consensus Estimate | 1.30 | 0.98 | 32.65 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 5.32 | 5.34 | -0.37 |
| EPS, GAAP | 4.09 | 3.22 | 27.02 |
| Consensus Estimate | 5.12 | NA | NA |
| SHPGY | Industry Average | |
| P/E (TTM) | 25.33 | 29.30 |
| P/E (Forward) | 17.04 | 4.90 |
| PEG Ratio | 1.06 | 0.22 |
| Price/Sales | 5.06 | 4.56 |
| Beta | 0.79 | 0.74 |
| 9:48 AM | 2/9/2012 | Shire's Profits and Sales Beat Views, Forecasts Strong 2012 |
| 7:38 AM | 2/9/2012 | Shire 4Q Pretax Profit $296.3M, Sees Good 2012 Earnings Growth |
| 1/24/2012 | Sanofi Says FDA Approved Genzyme's New Plant (WSJ.com) |
| 12/29/2011 | Alexion makes a big purchase. (The Motley Fool) |
| 12/15/2011 | Vertex CEO to Step Down (WSJ.com) |
| 12/12/2011 | Studies Could Ease Fears of ADHD Drugs (WSJ.com) |
| 12/7/2011 | Another delay for Protalix BioTherapeutics makes you think. (The Motley Fool) |
| 11/23/2011 | Stock Charts Point to Near-Term Risk, Rewards Later (Barrons.com) |
| 11/22/2011 | Market-lagging returns could be written in these two stars. (The Motley Fool) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
